Sermorelin is a GHRH analogue (1‑29) used in research to trigger natural pituitary release of growth hormone (GH).

It mimics endogenous GHRH, stimulating the pituitary gland to increase GH secretion in a physiological, pulsatile pattern, preserving negative feedback mechanisms and avoiding overshoot associated with direct GH administration.